Annual CFO
-$13.95 M
-$1.21 M-9.48%
December 1, 2023
Summary
- As of February 10, 2025, SKYE annual cash flow from operations is -$13.95 million, with the most recent change of -$1.21 million (-9.48%) on December 1, 2023.
- During the last 3 years, SKYE annual CFO has fallen by -$7.90 million (-130.46%).
- SKYE annual CFO is now -734426.32% below its all-time high of $1900.00, reached on October 1, 2012.
Performance
SKYE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$5.26 M
+$1.83 M+25.81%
September 1, 2024
Summary
- As of February 10, 2025, SKYE quarterly cash flow from operations is -$5.26 million, with the most recent change of +$1.83 million (+25.81%) on September 1, 2024.
- Over the past year, SKYE quarterly CFO has dropped by -$554.60 thousand (-11.78%).
- SKYE quarterly CFO is now -64279.27% below its all-time high of $8200.00, reached on July 1, 2013.
Performance
SKYE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$20.91 M
-$1.21 M-6.13%
September 1, 2024
Summary
- As of February 10, 2025, SKYE TTM cash flow from operations is -$20.91 million, with the most recent change of -$1.21 million (-6.13%) on September 1, 2024.
- Over the past year, SKYE TTM CFO has dropped by -$6.31 million (-43.22%).
- SKYE TTM CFO is now -1493400.00% below its all-time high of -$1400.00, reached on April 1, 2014.
Performance
SKYE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SKYE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.5% | -11.8% | -43.2% |
| 3 y3 years | -130.5% | -155.9% | -112.5% |
| 5 y5 years | -253.8% | -155.9% | -112.5% |
SKYE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -115.5% | at low | -167.3% | +25.8% | -222.9% | at low |
| 5 y | 5-year | -131.5% | at low | -411.9% | +25.8% | -295.6% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +25.8% | <-9999.0% | at low |
Skye Bioscience Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.26 M(-25.8%) | -$20.91 M(+6.1%) |
| Jun 2024 | - | -$7.09 M(+50.7%) | -$19.70 M(+34.9%) |
| Mar 2024 | - | -$4.71 M(+22.5%) | -$14.60 M(+4.6%) |
| Dec 2023 | -$13.95 M(+9.5%) | -$3.84 M(-5.2%) | -$13.95 M(-6.9%) |
| Sep 2023 | - | -$4.05 M(+103.6%) | -$14.98 M(+15.4%) |
| Jun 2023 | - | -$1.99 M(-51.0%) | -$12.98 M(-6.5%) |
| Mar 2023 | - | -$4.06 M(-16.6%) | -$13.89 M(+9.0%) |
| Dec 2022 | -$12.74 M(+96.8%) | -$4.87 M(+136.9%) | -$12.74 M(+29.5%) |
| Sep 2022 | - | -$2.06 M(-29.1%) | -$9.84 M(+6.1%) |
| Jun 2022 | - | -$2.90 M(-0.5%) | -$9.27 M(+15.3%) |
| Mar 2022 | - | -$2.91 M(+48.0%) | -$8.04 M(+24.2%) |
| Dec 2021 | -$6.47 M(+7.0%) | -$1.97 M(+32.5%) | -$6.47 M(+2.9%) |
| Sep 2021 | - | -$1.49 M(-11.1%) | -$6.29 M(-7.2%) |
| Jun 2021 | - | -$1.67 M(+24.0%) | -$6.78 M(+10.5%) |
| Mar 2021 | - | -$1.35 M(-24.5%) | -$6.14 M(+1.4%) |
| Dec 2020 | -$6.05 M(+0.4%) | -$1.79 M(-9.5%) | -$6.05 M(+4.9%) |
| Sep 2020 | - | -$1.97 M(+92.0%) | -$5.77 M(+9.2%) |
| Jun 2020 | - | -$1.03 M(-18.8%) | -$5.29 M(-9.8%) |
| Mar 2020 | - | -$1.27 M(-15.8%) | -$5.86 M(-2.7%) |
| Dec 2019 | -$6.03 M(+52.9%) | -$1.50 M(+1.0%) | -$6.03 M(+8.8%) |
| Sep 2019 | - | -$1.49 M(-7.3%) | -$5.54 M(+13.8%) |
| Jun 2019 | - | -$1.61 M(+12.2%) | -$4.87 M(+12.6%) |
| Mar 2019 | - | -$1.43 M(+41.1%) | -$4.32 M(+9.6%) |
| Dec 2018 | -$3.94 M | -$1.01 M(+24.2%) | -$3.94 M(-22.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$816.30 K(-22.9%) | -$5.07 M(+16.4%) |
| Jun 2018 | - | -$1.06 M(+0.6%) | -$4.36 M(+22.1%) |
| Mar 2018 | - | -$1.05 M(-50.9%) | -$3.57 M(+7.1%) |
| Dec 2017 | -$3.33 M(-6.2%) | -$2.14 M(+2043.5%) | -$3.33 M(+80.0%) |
| Sep 2017 | - | -$100.00 K(-63.2%) | -$1.85 M(-18.2%) |
| Jun 2017 | - | -$271.40 K(-66.8%) | -$2.26 M(-29.8%) |
| Mar 2017 | - | -$816.40 K(+23.2%) | -$3.22 M(-9.3%) |
| Dec 2016 | -$3.55 M(-4.7%) | -$662.80 K(+29.5%) | -$3.55 M(-11.3%) |
| Sep 2016 | - | -$511.70 K(-58.4%) | -$4.00 M(-16.4%) |
| Jun 2016 | - | -$1.23 M(+7.1%) | -$4.79 M(+16.1%) |
| Mar 2016 | - | -$1.15 M(+3.1%) | -$4.12 M(+10.6%) |
| Dec 2015 | -$3.73 M(+112.4%) | -$1.11 M(-14.0%) | -$3.73 M(+42.6%) |
| Sep 2015 | - | -$1.29 M(+128.1%) | -$2.61 M(+98.1%) |
| Jun 2015 | - | -$567.70 K(-24.5%) | -$1.32 M(+77.4%) |
| Mar 2015 | - | -$751.70 K(-9615.2%) | -$743.80 K(>+9900.0%) |
| Dec 2014 | -$1.76 M(>+9900.0%) | - | - |
| Jul 2014 | - | $7900.00(+139.4%) | -$1700.00(+21.4%) |
| Apr 2014 | - | $3300.00(-180.5%) | -$1400.00(-77.4%) |
| Jan 2014 | - | -$4100.00(-53.4%) | -$6200.00(-57.5%) |
| Oct 2013 | -$14.50 K(-863.2%) | -$8800.00(-207.3%) | -$14.60 K(+151.7%) |
| Jul 2013 | - | $8200.00(-646.7%) | -$5800.00(-58.6%) |
| Apr 2013 | - | -$1500.00(-88.0%) | -$14.00 K(+12.0%) |
| Jan 2013 | - | -$12.50 K | -$12.50 K |
| Oct 2012 | $1900.00 | - | - |
FAQ
- What is Skye Bioscience annual cash flow from operations?
- What is the all time high annual CFO for Skye Bioscience?
- What is Skye Bioscience annual CFO year-on-year change?
- What is Skye Bioscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for Skye Bioscience?
- What is Skye Bioscience quarterly CFO year-on-year change?
- What is Skye Bioscience TTM cash flow from operations?
- What is the all time high TTM CFO for Skye Bioscience?
- What is Skye Bioscience TTM CFO year-on-year change?
What is Skye Bioscience annual cash flow from operations?
The current annual CFO of SKYE is -$13.95 M
What is the all time high annual CFO for Skye Bioscience?
Skye Bioscience all-time high annual cash flow from operations is $1900.00
What is Skye Bioscience annual CFO year-on-year change?
Over the past year, SKYE annual cash flow from operations has changed by -$1.21 M (-9.48%)
What is Skye Bioscience quarterly cash flow from operations?
The current quarterly CFO of SKYE is -$5.26 M
What is the all time high quarterly CFO for Skye Bioscience?
Skye Bioscience all-time high quarterly cash flow from operations is $8200.00
What is Skye Bioscience quarterly CFO year-on-year change?
Over the past year, SKYE quarterly cash flow from operations has changed by -$554.60 K (-11.78%)
What is Skye Bioscience TTM cash flow from operations?
The current TTM CFO of SKYE is -$20.91 M
What is the all time high TTM CFO for Skye Bioscience?
Skye Bioscience all-time high TTM cash flow from operations is -$1400.00
What is Skye Bioscience TTM CFO year-on-year change?
Over the past year, SKYE TTM cash flow from operations has changed by -$6.31 M (-43.22%)